BIO Forum focuses on investment strategies.
Share:
Press Release Summary:
Scheduled for Oct 28-29, 2009, 8th Annual BIO Investor Forum focuses on investment strategies and competitive therapeutic and drug development innovations. Program will feature more than 110 late-stage private and emerging public company presentations, therapeutic panels led by clinical thought leaders, business roundtables addressing key issues affecting biotech executives, partnering meetings, and number of networking opportunities.
Original Press Release:
8th Annual BIO Investor Forum Highlights Late-Stage Private and Emerging Public Companies
WASHINGTON, D.C. (Thursday, July 30, 2009) - Registration is now available for the 8th Annual BIO Investor Forum - a national meeting focused on investment strategies and competitive therapeutic and drug development innovations. The event will take place October 28-29, 2009 at the Palace Hotel in San Francisco, Calif.
"The BIO Investor Forum is a world class venue for investors and companies to engage in candid discussions with their peers, hear about the latest life sciences investment trends, and discuss the issues affecting product development, capital formation, and commercialization," said Alan Eisenberg, executive vice president, Emerging Companies & Business Development at BIO.
The BIO Investor Forum is a must attend event for public and private market investors, research analysts, investment bankers, and industry executives focused on investment and business development opportunities in the life sciences. The program will feature more than 110 late-stage private and emerging public company presentations, therapeutic panels led by clinical thought leaders, business roundtables addressing key issues affecting biotech executives, partnering meetings, and a number of networking opportunities.
To learn more about the BIO Investor Forum, including registration and program information, please visit investorforum.bio.org/. Registration is complimentary for qualified investors.
The BIO Investor Forum is a national investor conference featuring leading private and emerging public companies. The meeting attracts sophisticated healthcare venture capital and public market investors and research analysts. In addition, the BIO Investor Forum draws business development executives from leading global pharmaceutical and biotechnology companies.
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
Contact Erin Reese
202-962-9235
